Company intelligence / Profile preview

Jiuzhitang

Changsha, Hunan, China

Ownership: Private
Employees: ~3519
Development stage: Other

Overview

Jiuzhitang is a leading Chinese pharmaceutical company specializing in the manufacture, R&D, and distribution of traditional Chinese medicines with over 300 products on the market. The company has expanded into regenerative medicine with investments in cGMP-grade stem cell production facilities and international collaborations. Its core business remains commercialized OTC/prescription drugs based on TCM, while its regenerative medicine pipeline is at an early clinical or pre-clinical stage[1][2][5][6][7][10].

Therapeutic areas: DermatologyGastroenterologyNeurologyCardiovascular
Modalities: Small molecule (traditional Chinese medicine formulations)Cell therapy (stem cell therapy)
Industry: Biotech

Partnerships

Stemedica Cell Technology Inc. ("Stemedica", USA), collaboration for clinical-grade stem cells and technology transfer

Beyond the preview

Go deeper on Jiuzhitang.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiuzhitang.

Explore the full profile